GlassScriptPhysician profile
Ayman Barakat
NPI 1134320328
$13,172.28
in general payments reported to CMS, 2019-2025
77 companies · $2,541 in 2025
The $2,541 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,690 · 2020: $1,399 · 2021: $1,111 · 2022: $1,677 · 2023: $2,186 · 2024: $2,568 · 2025: $2,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,295.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,040.01 | 2019-2025 | |
| Celgene Corporation | $860.67 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Janssen Biotech, INC. | $790.63 | 2019-2025 | Rybrevant, Tecvayli, Talvey |
| Merck Sharp & Dohme LLC | $765.83 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $705.91 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $630.24 | 2019-2025 | Opdivo, Krazati, Augtyro |
| Astrazeneca Pharmaceuticals LP | $578.49 | 2019-2025 | Lynparza, Calquence, Imfinzi |
| Seagen INC. | $538.63 | 2019-2023 | Padcev, Adcetris, Tukysa |
| Astellas Pharma US INC | $506.64 | 2019-2025 | Padcev, Xtandi, Vyloy |
| Genentech USA, INC. | $482.73 | 2019-2024 | Tecentriq, Polivy, Alecensa |
| Gilead Sciences, INC. | $445.87 | 2021-2025 | Trodelvy |
| Genzyme Corporation | $394.15 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $367.40 | 2019-2025 | |
| Lilly USA, LLC | $365.52 | 2020-2025 | Verzenio, Jaypirca, Retevmo |
| Amgen INC. | $336.65 | 2019-2023 | Lumakras, Nplate, Vectibix |
Show all 77 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $330.77 | 2019-2025 | Venclexta |
| Eisai INC. | $305.23 | 2019-2025 | |
| Incyte Corporation | $222.20 | 2019-2025 | Monjuvi, Zynyz, Jakafi |
| Glaxosmithkline, LLC. | $220.12 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Regeneron Healthcare Solutions, INC. | $192.01 | 2021-2025 | Libtayo |
| Daiichi Sankyo INC. | $140.23 | 2020-2025 | Enhertu |
| Ipsen Biopharmaceuticals, INC | $125.53 | 2019-2025 | Somatuline Depot, Onivyde |
| Kite Pharma, INC. | $121.25 | 2023-2025 | Yescarta |
| Puma Biotechnology, INC. | $120.74 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $111.62 | 2019-2024 | Alunbrig, Fruzaqla, Iclusig |
| Beone Medicines USA, INC. | $106.87 | 2025 | Tevimbra, Brukinsa |
| Taiho Oncology, INC. | $103.63 | 2024-2025 | |
| Emd Serono, INC. | $100.57 | 2019-2024 | |
| Dendreon Pharmaceuticals LLC | $92.92 | 2022-2025 | Provenge |
| Jazz Pharmaceuticals INC. | $92.54 | 2022-2025 | |
| Pharmacosmos Therapeutics INC. | $92.37 | 2023-2025 | Cosela, Monoferric |
| Aveo Pharmaceuticals, INC. | $90.31 | 2021-2024 | Fotivda |
| Beigene USA, INC. | $88.67 | 2020-2024 | Brukinsa, Tevimbra |
| Array Biopharma INC | $84.22 | 2019-2025 | Braftovi, Lorbrena, Mektovi |
| Octapharma USA, INC. | $81.98 | 2020 | |
| Sobi, INC | $79.77 | 2023-2025 | |
| Stemline Therapeutics INC. | $79.09 | 2023-2025 | Orserdu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.03 | 2020-2022 | |
| Kyowa Kirin, INC. | $70.62 | 2019-2025 | Poteligeo |
| Alexion Pharmaceuticals, INC. | $70.57 | 2019-2025 | Ultomiris |
| Csl Behring | $70.51 | 2022-2024 | Afstyla, Idelvion |
| Ge Healthcare | $65.39 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $63.99 | 2022-2023 | Imbruvica |
| Tersera Therapeutics LLC | $57.93 | 2019 | |
| Amag Pharmaceuticals, INC. | $55.56 | 2019-2021 | |
| G1 Therapeutics, INC. | $54.05 | 2022-2023 | Cosela |
| Recordati_rare_diseases_inc. | $53.80 | 2025 | Enjaymo |
| Karyopharm Therapeutics INC. | $52.37 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $52.24 | 2019 | |
| Deciphera Pharmaceuticals INC. | $50.10 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $36.76 | 2024 | Orgovyx |
| Heron Therapeutics, INC. | $36.63 | 2021 | |
| Exelixis INC. | $34.77 | 2023-2024 | Cabometyx |
| Cti Biopharma Corp. | $34.21 | 2023 | Vonjo |
| Epizyme, INC. | $31.67 | 2021 | |
| Tesaro, INC. | $31.31 | 2019 | |
| Immunocore Limited | $27.26 | 2025 | Kimmtrak |
| Secura Bio, INC. | $25.27 | 2020-2022 | |
| Mirati Therapeutics, INC. | $23.87 | 2024 | Krazati |
| Tempus Ai, INC | $22.83 | 2024 | Xt Cdx |
| Geron Corporation | $22.79 | 2025 | Rytelo |
| Fennec Pharmaceuticals, INC. | $22.71 | 2025 | Fyarro |
| Immunogen, INC. | $22.19 | 2023 | Elahere |
| Genmab U.S., INC. | $20.79 | 2024 | Epkinly |
| Pharmaessentia USA Corporation | $20.35 | 2023 | Besremi |
| Morphosys, US INC. | $18.28 | 2023 | Monjuvi |
| Tg Therapeutics, INC. | $17.84 | 2021 | |
| Dova Pharmaceuticals | $17.55 | 2021 | |
| Acceleron Pharma, INC. | $17.09 | 2020 | |
| Agios Pharmaceuticals, INC. | $17.08 | 2024 | |
| Apellis Pharmaceuticals, INC. | $15.01 | 2023 | Empaveli |
| Myovant Sciences INC. | $14.97 | 2021 | |
| Sun Pharmaceutical Industries INC. | $13.29 | 2020 | |
| Global Blood Therapeutics, INC. | $12.49 | 2020 | |
| Foundation Medicine, INC. | $12.48 | 2022 | |
| Eusa Pharma (US) LLC | $11.77 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
Keytruda $443Reblozyl $351Padcev $350Kisqali $260Opdivo $227Pluvicto $213Lenvima $204Nubeqa $199Sarclisa $188Rybrevant $172Enhertu $168Verzenio $166Tukysa $166Xofigo $157Lynparza $156Libtayo $153Xtandi $147Jaypirca $147Adcetris $143Monjuvi $139Ibrance $134Trodelvy $113Imbruvica $109Retevmo $107Lutathera $107Brukinsa $106Lonsurf $104Inqovi $104Elahere $98.45Vonjo $94.76Yescarta $93.08Opdualag $85.94Ojjaara $83.25Cosela $81.79Tecvayli $81.29Orserdu $79.09Onivyde $78.43Somatuline Depot $78.43Orgovyx $74.99Elrexfio $74.68Tevimbra $74.27Zepzelca $72.87Scemblix $72.48Fabhalta $70.85Venclexta $67.48Provenge $63.47Talvey $63.33Nerlynx $62.47Fotivda $60.27Lorbrena $54.42Braftovi $54.42Enjaymo $53.80Afstyla $50.84Idelvion $50.84Erleada $49.14Poteligeo $47.58Calquence $46.44Darzalex $45.01Monoferric $44.74Inlyta $44.47Tivdak $42.50Imfinzi $42.07Alunbrig $42.06Stivarga $41.69Vitrakvi $41.69Ultomiris $40.28Krazati $39.36Zynyz $38.94Talzenna $38.23Emrelis $37.79Carvykti $36.46Vyloy $36.30Cabometyx $34.77Tabrecta $34.76Welireg $33.92Fruzaqla $33.33Lumakras $32.94Mektovi $31.98Ayvakit $30.29Kimmtrak $27.26Jakafi $26.88Keytruda Qlex $26.63Comirnaty $24.36Piqray $23.47Zejula $23.28Jemperli $23.28Xt Cdx $22.83Rytelo $22.79Fyarro $22.71Pomalyst $22.27Epkinly $20.79Besremi $20.35Doptelet $19.22Xgeva $19.22Vectibix $19.22Nplate $19.22Oxbryta $19.17Tasigna $19.06Mekinist $17.25Elitek $17.08
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayman Barakat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.